METABOLIC EFFECTS OF DIFFERENT LIPID-LOWERING THERAPY REGIMENS IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK

被引：0
|
作者：
Koshelskaya, O. [1 ]
Sushkova, A. [1 ]
Kravtshenko, E. [1 ]
Suslova, T. [1 ]
机构：
[1] Russian Acad Sci, Cardiol Res Inst, Tomsk Natl Res Med Ctr, Tomsk, Russia
来源：
JOURNAL OF HYPERTENSION | 2017年 / 35卷
关键词：
D O I：
10.1097/01.hjh.0000523535.39716.04
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.12.26
引用
收藏
页码：E193 / E194
页数：2
相关论文
共 50 条
  • [31] Lipid-lowering therapy for patients with or at risk of coronary artery disease
    Kjekshus, J
    Pedersen, TR
    Tobert, JA
    CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 418 - 427
  • [32] Changes in lipid-lowering therapy following a cardiovascular event in patients with diabetes
    Okerson, T.
    Cohen, S. S.
    Killian, J. M.
    Weston, S. A.
    Monda, K. L.
    Chamberlain, A. M.
    DIABETOLOGIA, 2017, 60 : S537 - S538
  • [33] The Effectiveness of Outpatient and Hospital Lipid-lowering Therapy in Patients with High and Very High Cardiovascular Risk during 2011-2015
    Smetnev, Stepan A.
    Ershova, Alexandra I.
    Bogdanova, Radmila S.
    Meshkov, Alexey N.
    Boytsov, Sergey A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2016, 12 (06) : 622 - 630
  • [34] Optimization of Lipid-Lowering Therapy for High Cardiovascular Risk Patients Through Electronic Medical Record Reporting and Pharmacist Evaluation
    Chen, Kaylee
    Canfield, Scott
    Blackwell, Joshua
    Houmes, Samuel
    Jones, Steven
    Lindsley, John
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (08): : 1010 - 1016
  • [35] Lipid-lowering therapy in high cardiovascular risk patients during COVID-19 pandemic: keep focused on the target
    Cesaro, Arturo
    Riccio, Carmine
    Calabro, Paolo
    MONALDI ARCHIVES FOR CHEST DISEASE, 2021, 91 (02)
  • [36] The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
    Penson, Peter E.
    Banach, Maciej
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (11)
  • [37] The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
    Peter E. Penson
    Maciej Banach
    Current Atherosclerosis Reports, 2020, 22
  • [38] Patients' pill burden predicts adherence to anti hypertensive and lipid-lowering therapy
    Benner, JS
    Petrilla, AA
    Schwartz, JS
    Tang, S
    Rosenberg, N
    Chapman, RH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 263A - 263A
  • [39] The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
    Cherry, Spencer B.
    Benner, Joshua S.
    Hussein, Mohamed A.
    Tang, Simon S. K.
    Nichol, Michael B.
    VALUE IN HEALTH, 2009, 12 (04) : 489 - 497
  • [40] Lipid-lowering therapy - New and established agents reduce risk of cardiovascular events
    Smith, CR
    POSTGRADUATE MEDICINE, 2004, 115 (03) : 29 - +
12345